🇺🇸 FDA
Patent

US 8298589

Nitrite formulations and their use as nitric oxide prodrugs

granted A61KA61K31/195A61K31/375

Quick answer

US patent 8298589 (Nitrite formulations and their use as nitric oxide prodrugs) held by The Board of Regents of the University of Texas System expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/195, A61K31/375, A61K33/00